{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:20:32Z","timestamp":1788477632327,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Insulin resistance (IR) constitutes a critical pathophysiological mechanism linking pediatric obesity to type 2 diabetes mellitus (T2DM) and cardiovascular disease. Recent investigations in adult populations have proposed 20\/ fasting C-peptide \u00d7 fasting plasma glucose (20\/ (Fcpep X FBG)) as a good biomarker for IR. We aimed to evaluate the diagnostic utility of this novel index in detecting IR among obese pediatric patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This case-control study included 100 children (50 obese and 50 controls), aged 6\u201316 years. Anthropometric, clinical, and laboratory assessments were performed, including fasting blood glucose, fasting serum insulin, fasting C-peptide, and lipid profile. IR was evaluated using HOMA-IR, HbA1c, TyG index, and 20\/ (Fcpep X FBG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Obese children demonstrated significantly elevated metabolic parameters, including body mass index (BMI), HOMA-IR, and fasting C-peptide. The (20\/Fcpep x FBG) index was significantly lower in obese subjects (0.10\u2009\u00b1\u20090.04 vs. 0.18\u2009\u00b1\u20090.05,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and exhibited strong inverse correlations with HOMA-IR, BMI, TyG index, and HbA1c. 20\/ Fcpep X FBG can significantly predict IR at a cut-off \u22640.164 with 86.67% sensitivity, 85% specificity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The 20\/ (Fcpep X FBG) index represents a convenient and accurate biomarker for IR detection in obese pediatric populations, demonstrating robust correlations with established metabolic indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Insulin resistance (IR) constitutes a critical pathophysiological mechanism linking pediatric obesity to type 2 diabetes mellitus (T2DM) and cardiovascular disease.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Homeostatic model assessment of insulin resistance (HOMA-IR) and Triglyceride glucose (TyG) index serve as the established surrogate markers; recent investigations in adult populations have proposed 20\/ fasting C-peptide \u00d7 fasting plasma glucose (20\/ (Fcpep X FBG) as a superior alternative. However, its utility in pediatric patients with obesity has not been evaluated.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>We found that the (20\/ (Fcpep X FBG) is a promising and reliable marker for detecting IR in obese children and adolescents.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-026-05251-6","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:44:22Z","timestamp":1782445462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["20\/ (fasting C-peptide \u00d7 fasting plasma glucose) as a novel marker for insulin resistance in obese children and adolescents"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7836-1170","authenticated-orcid":false,"given":"Doaa","family":"El Amrousy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"El Shall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"5251_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/pedi.12964","volume":"21","author":"C Frithioff-B\u00f8js\u00f8e","year":"2020","unstructured":"Frithioff-B\u00f8js\u00f8e, C. et al. Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity. Pediatr. Diab 21, 194\u2013202 (2020).","journal-title":"Pediatr. Diab"},{"key":"5251_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S2352-4642(17)30044-5","volume":"1","author":"R Weiss","year":"2017","unstructured":"Weiss, R. et al. Prediabetes in youths: Mechanisms and biomarkers. Lancet Child Adolesc. Health 1, 240\u2013248 (2017).","journal-title":"Lancet Child Adolesc. Health"},{"key":"5251_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/17477166.2011.583661","volume":"6","author":"O Volovelsky","year":"2011","unstructured":"Volovelsky, O. & Weiss, R. Fatty liver disease in obese children\u2013relation to other metabolic risk factors. Int J. Pediatr. Obes. 6, 59\u201364 (2011).","journal-title":"Int J. Pediatr. Obes."},{"key":"5251_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.6065\/apem.2040090.045","volume":"25","author":"V Castorani","year":"2020","unstructured":"Castorani, V., Polidori, N., Giannini, C., Blasetti, A. & Chiarelli, F. Insulin resistance and type 2 diabetes in children. Ann. Pediatr. Endocrinol. Metab. 25, 217\u2013226 (2020).","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"5251_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1463-1326.2012.01643.x","volume":"14","author":"C Giannini","year":"2012","unstructured":"Giannini, C. & Caprio, S. Islet function in obese adolescents. Diab Obes. Metab. 14, 40\u201345 (2012).","journal-title":"Diab Obes. Metab."},{"key":"5251_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000183894","volume":"71","author":"F Eyzaguirre","year":"2009","unstructured":"Eyzaguirre, F. & Mericq, V. Insulin resistance markers in children. Horm. Res Paediatr. 71, 65\u201374 (2009).","journal-title":"Horm. Res Paediatr."},{"key":"5251_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0168-8227(99)00116-3","volume":"47","author":"M Gutt","year":"2000","unstructured":"Gutt, M. et al. Validation of the insulin sensitivity index (ISI0, 120): Comparison with other measures. Diab Res Clin. Pract. 47, 177\u2013184 (2000).","journal-title":"Diab Res Clin. Pract."},{"key":"5251_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s00431-025-06632-5","volume":"184","author":"O Taha","year":"2025","unstructured":"Taha, O., Abdulla, L., Erfan, A., Elsharaby, R. & El Amrousy, D. Triglyceride glucose index as a biomarker for different glucose disorders in overweight and obese children and adolescents. Eur. J. Pediatr. 184, 820 (2025).","journal-title":"Eur. J. Pediatr."},{"key":"5251_CR9","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.3390\/nu12113310","volume":"12","author":"FJ Rup\u00e9rez","year":"2020","unstructured":"Rup\u00e9rez, F. J., Martos-Moreno, G. \u00c1, Chamoso-S\u00e1nchez, D., Barbas, C. & Argente, J. Insulin resistance in obese children: What can metabolomics and adipokine modelling contribute? Nutrients 12, 3310 (2020).","journal-title":"Nutrients"},{"key":"5251_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1475-2840-12-21","volume":"12","author":"T Ohkura","year":"2013","unstructured":"Ohkura, T. et al. 20\/(fasting C-peptide\u00d7 fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: A preliminary report. Cardiovasc Diabetol. 12, 21 (2013).","journal-title":"Cardiovasc Diabetol."},{"key":"5251_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4274\/jcrpe.v2i3.100","volume":"2","author":"S Kurto\u011flu","year":"2010","unstructured":"Kurto\u011flu, S. et al. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J. Clin. Res Pediatr. Endocrinol. 2, 100\u2013106 (2010).","journal-title":"J. Clin. Res Pediatr. Endocrinol."},{"key":"5251_CR12","doi-asserted-by":"publisher","first-page":"110608","DOI":"10.1016\/j.nut.2019.110608","volume":"71","author":"RBC Chissini","year":"2020","unstructured":"Chissini, R. B. C., Kuschnir, M. C., de Oliveira, C. L., Giannini, D. T. & Santos, B. Cutoff values for HOMA-IR associated with metabolic syndrome in the Study of Cardiovascular Risk in Adolescents (ERICA Study). Nutrition 71, 110608 (2020).","journal-title":"Nutrition"},{"key":"5251_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/ajop.ajop_8_25","volume":"38","author":"A Elbarky","year":"2025","unstructured":"Elbarky, A., Mahmoud, M., Yousef, Y. F. & Elsawy, D. Hidden indicators of insulin resistance in childhood obesity. Alex. J. Pediatr. 38, 96\u2013103 (2025).","journal-title":"Alex. J. Pediatr."},{"key":"5251_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4274\/Jcrpe.1127","volume":"5","author":"Y Singh","year":"2013","unstructured":"Singh, Y., Garg, M. K., Tandon, N. & Marwaha, R. K. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J. Clin. Res Pediatr. Endocrinol. 5, 245\u2013251 (2013).","journal-title":"J. Clin. Res Pediatr. Endocrinol."},{"key":"5251_CR15","doi-asserted-by":"publisher","first-page":"852290","DOI":"10.3389\/fendo.2022.852290","volume":"13","author":"AKNZ Iwani","year":"2022","unstructured":"Iwani, A. K. N. Z. et al. TG: HDL-C ratio as insulin resistance marker for metabolic syndrome in children with obesity. Front Endocrinol. 13, 852290 (2022).","journal-title":"Front Endocrinol."},{"key":"5251_CR16","doi-asserted-by":"publisher","first-page":"108027","DOI":"10.1016\/j.diabres.2020.108027","volume":"160","author":"X Han","year":"2020","unstructured":"Han, X., Xu, P., Zhou, J., Liu, Y. & Xu, H. Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children. Diab Res Clin. Pr. 160, 108027 (2020).","journal-title":"Diab Res Clin. Pr."},{"key":"5251_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41390-021-01847-2","volume":"92","author":"AA Hassan","year":"2022","unstructured":"Hassan, A. A. et al. Urinary C-peptide and urinary C-peptide creatinine ratio as markers for insulin resistance in obese children and adolescents. Pediatr. Res 92, 805\u2013809 (2022).","journal-title":"Pediatr. Res"},{"key":"5251_CR18","first-page":"530","volume":"15","author":"J Kaur","year":"2025","unstructured":"Kaur, J., Singh, M., Bawa, R. S., Kaur, N. & Kaur, A. Association of fasting C-Peptide level with insulin resistance and anthropometric measures in diabetic patients. Eur. J. Cardiovasc Med 15, 530\u2013537 (2025).","journal-title":"Eur. J. Cardiovasc Med"},{"key":"5251_CR19","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/nu16132135","volume":"16","author":"IB Kosovski","year":"2024","unstructured":"Kosovski, I. B. et al. Evaluation of fasting glucose-insulin-C-peptide-derived metabolic indices for identifying metabolic syndrome in young, healthy adults. Nutrients 16, 2135 (2024).","journal-title":"Nutrients"},{"key":"5251_CR20","first-page":"5986","volume":"25","author":"E Kostopoulou","year":"2021","unstructured":"Kostopoulou, E., Tikka, M., Gil, A. R., Partsalaki, I. & Spiliotis, B. Glucose tolerance and insulin sensitivity markers in children and adolescents with excess weight. Eur. Rev. Med Pharm. Sci. 25, 5986\u20135992 (2021).","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"5251_CR21","first-page":"108","volume":"13","author":"K Patil","year":"2024","unstructured":"Patil, K., Chhajed, S. & Sude, A. C-peptide levels in diabetes mellitus type 2 patients and its correlation with obesity and insulin resistance. Indian J. Res 13, 108 (2024).","journal-title":"Indian J. Res"},{"key":"5251_CR22","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.sjbs.2018.05.027","volume":"25","author":"HA Khan","year":"2018","unstructured":"Khan, H. A., Sobki, S. H., Ekhzaimy, A., Khan, I. & Almusawi, M. A. Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals. Saudi J. Biol. Sci. 25, 1729\u20131732 (2018).","journal-title":"Saudi J. Biol. Sci."},{"key":"5251_CR23","first-page":"1719","volume":"14","author":"S Anoop","year":"2020","unstructured":"Anoop, S. et al. The triglyceride\/glucose ratio is a reliable index of fasting insulin resistance: Observations from hyperinsulinaemic-euglycaemic clamp studies in young, normoglycaemic males from southern India. Diab Metab. Syndr. Clin. Res Rev. 14, 1719\u20131723 (2020).","journal-title":"Diab Metab. Syndr. Clin. Res Rev."},{"key":"5251_CR24","first-page":"e66543","volume":"16","author":"BS Essa","year":"2024","unstructured":"Essa, B. S. & Meena, M. Q. Potential of fasting C-peptide to glucose ratio and triglyceride glucose index as markers for \u03b2-cell dysfunction and insulin resistance in patients with type 2 diabetes on insulin therapy. Cureus 16, e66543 (2024).","journal-title":"Cureus"},{"key":"5251_CR25","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.metabol.2013.05.022","volume":"62","author":"Y Okuno","year":"2013","unstructured":"Okuno, Y. et al. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test-and glucose clamp-based disposition indexes. Metabolism 62, 1470\u20131476 (2013).","journal-title":"Metabolism"},{"key":"5251_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3390\/ijms17050744","volume":"17","author":"Y Saisho","year":"2016","unstructured":"Saisho, Y. Postprandial C-peptide to glucose ratio as a marker of \u03b2 cell function: implication for the management of type 2 diabetes. Int. J. Mol. Sci. 17, 744 (2016).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05251-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:22:10Z","timestamp":1788434530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05251-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":26,"alternative-id":["5251"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05251-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study obtained ethical approval from the faculty of medicine\u2019s local Ethical Committee at Tanta University. The human subjects were enrolled following the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Participants and their parents provided a written consent form.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}